A New Era in Alzheimer's Disease: Examining the Ethics of Anti-Amyloid Treatment

Anti-amyloid treatment for Alzheimer’s disease has recently entered clinical use. The ability of anti-amyloid drugs to slow the progression of dementia is unprecedented. However, it is unknown how patients and their caregivers value a prolonged course of cognitive impairment and how they weigh its significance against the burdens posed by anti-amyloid treatment. Prof. Clapp and his team will interview and observe patients, caregivers, and clinicians as they make decisions about anti-amyloid treatment and interpret its effects. They will seek to use their findings to advance the ethical usage of anti-amyloid drugs.